Clinical Report: Somatic Comorbidities in Traumatic Brain Injury Survivors

Overview

This nationwide 25-year cohort study demonstrates that adults surviving traumatic brain injury (TBI) have an increased long-term risk of developing somatic comorbidities, including cerebrovascular disease, cancer, diabetes, and cardiovascular conditions. The study highlights a higher cumulative burden of somatic diseases in TBI survivors compared to matched controls, emphasizing the importance of monitoring and managing these conditions post-injury.

Background

Traumatic brain injuries contribute substantially to global disability, with survivors facing elevated risks of various somatic comorbidities. Prior research has predominantly focused on psychiatric outcomes or lacked large-scale, long-term data. Understanding the development of somatic diseases after TBI is critical for improving rehabilitation and reintegration strategies. This study leverages Danish national registries to analyze somatic health outcomes over 25 years in a large, age-matched cohort of TBI survivors and controls.

Data Highlights

The study included TBI survivors from 1994 to 2018, matched 1:5 by age with controls. TBI severity was categorized by hospital length of stay (1 day, 2–3 days, ≥4 days). Four key comorbidities—cerebrovascular disease, cancer, diabetes, and cardiovascular disease—were analyzed alongside the Charlson Comorbidity Index (CCI) scores to quantify somatic disease burden. Analyses were stratified by age groups: 18–39.9, 40–69.9, and ≥70 years.

Key Findings

• TBI survivors exhibit a significantly higher risk of developing cerebrovascular disease, cancer, diabetes, and cardiovascular disease compared to controls.
• The cumulative somatic comorbidity burden, measured by mean CCI scores, is elevated in TBI survivors across all age groups.
• Longer hospital stays (≥4 days) as a proxy for more severe TBI correlate with greater accumulation of somatic comorbidities.
• Exclusion of multiorgan trauma cases ensured that comorbidity accumulation is attributable primarily to TBI.
• Age stratification reveals that somatic comorbidity risks persist across young, middle-aged, and older adults post-TBI.

Clinical Implications

Clinicians should be aware of the heightened risk for somatic comorbidities in TBI survivors and incorporate regular screening and management of cerebrovascular, metabolic, oncologic, and cardiovascular conditions into long-term care plans. Recognizing the cumulative burden of these diseases can guide targeted interventions to improve rehabilitation outcomes and reduce secondary health decline.

Conclusion

This comprehensive nationwide study confirms that TBI survivors face increased long-term risks of multiple somatic comorbidities, underscoring the need for integrated, multidisciplinary approaches to their ongoing healthcare management.

References

1. Danish National Patient Registry Data and Charlson Comorbidity Index Framework
2. Previous Danish Register-Based Dementia Study [11]
3. Study on TBI Severity Classification and Length of Stay [35]